Your Scientists Just Spent 5 Years Developing a Drug. The FDA Said No. Now What?
Drug development is a marathon of hope and heartbreak. Your research teams pour years into compounds that might never reach patients.
When regulatory setbacks hit, it’s not just the science that suffers—it’s team morale and retention.
Much like predicting which compounds will pass clinical trials, you can’t guarantee regulatory success. But you can build resilience into your teams so they bounce back from setbacks stronger than before.

HOW ERIC’S CONTENT APPLIES
Eric Termuende’s “Blueprint to the Future” keynote shows your leadership practical strategies to boost trust, resilience, and camaraderie—helping your teams stay motivated through the inevitable ups and downs of pharmaceutical development.
In a world where change is constant and unpredictable, the winners won’t be those who guess right—but those who build a team that is ready for whatever comes next.
KEYNOTES/TOPICS
Blueprint to the Future

Snowflakes and Fingerprints

Uncertainty

Generation All

Leadership and AI
